FDA Panel Supports Gene Therapy for Kids With Rare Eye Disease

Tuesday, October 17, 2017

A U.S. Food and Drug Administration advisory panel on Thursday recommended approval of a gene therapy that could grant the gift of sight to young people with a rare type of inherited vision loss. Foundation Fighting Blindness Chief Research Officer, Stephen M. Rose, PhD, discusses this gene thearpy with Everyday Health. Read the full article on this treatment here.